Trilysine Acetate

If you're formulating a polymeric hydrogel system and sourcing trilysine acetate (CAS: 13184-14-0) is on your critical path, the details here are worth your attention. This excipient sits at the center of several commercially proven product categories: surgical sealants and tissue adhesives, wound closure solutions, hemostatic patches, ophthalmic sealants, controlled drug delivery depots, and radiotherapy hydrogel spacer systems. That's not a speculative application list; these are categories with marketed products already depending on this molecule.

Curia manufactures trilysine acetate at its Valladolid, Spain facility, backed by more than 30 years of development and commercialization experience with complex small molecules and peptide-like structures. For procurement teams evaluating supply chain risk, the second-source supply positioning matters as much as the chemistry credentials.

Scalability, timeline efficiency, and cost-effective execution round out the manufacturing value proposition. If your program is moving toward late-stage development or you're already in commercial supply and need a qualified alternate source, this is a conversation worth starting sooner rather than later.

Contact Curia directly to request a sample and align on your project specifications.